54 related articles for article (PubMed ID: 21590386)
1. Tumor markers in clinical practice: a review focusing on common solid cancers.
Duffy MJ
Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
[TBL] [Abstract][Full Text] [Related]
2. Microchip-based detection of magnetically labeled cancer biomarkers.
Muluneh M; Issadore D
Adv Drug Deliv Rev; 2014 Feb; 66():101-9. PubMed ID: 24099664
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of oncofetal proteins and hormones as tumor markers.
Garrett PE; Kurtz SR
Med Clin North Am; 1986 Nov; 70(6):1295-306. PubMed ID: 2431237
[TBL] [Abstract][Full Text] [Related]
4. Epithelial tumor markers: oncofetal antigens (carcinoembryonic antigen, alpha fetoprotein) and epithelial membrane antigen.
Klöppel G; Caselitz J
Curr Top Pathol; 1987; 77():103-32. PubMed ID: 2448086
[No Abstract] [Full Text] [Related]
5. Diagnosis of cancer using microchip-based system for simultaneous quantitation of six tumor markers.
Ryabykh TP; Sokolova ZA; Paklin NB; Osipova TV
Dokl Biochem Biophys; 2011; 437():98-101. PubMed ID: 21590386
[No Abstract] [Full Text] [Related]
6. Microchip-based multiplex electro-immunosensing system for the detection of cancer biomarkers.
Ko YJ; Maeng JH; Ahn Y; Hwang SY; Cho NG; Lee SH
Electrophoresis; 2008 Aug; 29(16):3466-76. PubMed ID: 18651704
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
8. Tumor marker workshops.
Rye PD; Nustad K; Stigbrand T
Tumour Biol; 2003; 24(4):165-71. PubMed ID: 14654709
[TBL] [Abstract][Full Text] [Related]
9. [Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer].
Honda T; Katusima S; Tokuda Y; Matuda K; Oonisi Y; Taniguchi T; Oomoto J; Kawaguchi Y
Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):521-6. PubMed ID: 6206171
[No Abstract] [Full Text] [Related]
10. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
11. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.
Voorzanger-Rousselot N; Garnero P
Cancer Treat Rev; 2007 May; 33(3):230-83. PubMed ID: 17433551
[TBL] [Abstract][Full Text] [Related]
12. Protein microchips in quantitative assays for tumor markers.
Dementieva EI; Rubina AY; Darii EL; Dyukova VI; Zasedatelev AS; Osipova TV; Ryabykh TP; Baryshnikov AY; Mirzabekov AD
Dokl Biochem Biophys; 2004; 395():88-92. PubMed ID: 15253559
[No Abstract] [Full Text] [Related]
13. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
[TBL] [Abstract][Full Text] [Related]
14. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
15. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.
Zweig MH; Campbell G
Clin Chem; 1993 Apr; 39(4):561-77. PubMed ID: 8472349
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
